New Age Alpha Advisors LLC Invests $2.41 Million in Healthpeak Properties, Inc. (NYSE:DOC)

New Age Alpha Advisors LLC purchased a new stake in Healthpeak Properties, Inc. (NYSE:DOC) in the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 118,683 shares of the real estate investment trust’s stock, valued at approximately $2,406,000.

Several other institutional investors have also added to or reduced their stakes in DOC. State Street Corp acquired a new stake in shares of Healthpeak Properties during the third quarter worth $1,093,576,000. JPMorgan Chase & Co. increased its position in Healthpeak Properties by 23.2% during the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after acquiring an additional 4,056,931 shares during the period. Principal Financial Group Inc. raised its stake in Healthpeak Properties by 2,113.5% in the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock worth $367,575,000 after purchasing an additional 17,314,572 shares in the last quarter. Geode Capital Management LLC bought a new stake in Healthpeak Properties in the 3rd quarter valued at about $403,898,000. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Healthpeak Properties by 0.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 10,153,450 shares of the real estate investment trust’s stock valued at $205,810,000 after purchasing an additional 53,392 shares during the period. 93.57% of the stock is currently owned by institutional investors.

Healthpeak Properties Price Performance

DOC stock opened at $20.20 on Friday. The stock has a market cap of $14.13 billion, a price-to-earnings ratio of 57.70, a P/E/G ratio of 2.17 and a beta of 1.14. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The company has a 50 day simple moving average of $20.23 and a 200 day simple moving average of $21.10. Healthpeak Properties, Inc. has a 1 year low of $17.80 and a 1 year high of $23.26.

Healthpeak Properties Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were issued a dividend of $0.305 per share. The ex-dividend date was Friday, February 14th. This is an increase from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a dividend yield of 6.04%. Healthpeak Properties’s dividend payout ratio is 348.57%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the stock. StockNews.com upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Saturday, March 22nd. Wedbush dropped their price objective on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, February 14th. Scotiabank reduced their target price on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a report on Friday, February 28th. Wells Fargo & Company dropped their price target on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. Finally, Robert W. Baird reduced their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Tuesday, February 11th. Four research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $23.92.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.